- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2049-3002
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
SGLT2 inhibition slows tumor growth in mice by reversing hyperinsulinemia ; volume:7 ; number:1 ; day:11 ; month:12 ; year:2019 ; pages:1-13 ; date:12.2019
Cancer & metabolism ; 7, Heft 1 (11.12.2019), 1-13, 12.2019
- Urheber
-
Nasiri, Ali R.
Rodrigues, Marcos R.
Li, Zongyu
Leitner, Brooks P.
Perry, Rachel J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40170-019-0203-1
- URN
-
urn:nbn:de:101:1-2020040512484890747807
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Nasiri, Ali R.
- Rodrigues, Marcos R.
- Li, Zongyu
- Leitner, Brooks P.
- Perry, Rachel J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
SGLT2-inhibition in patients with Alport syndrome
SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob−/− mice
Reversing Fields
Reversing Emissions
Reversing Emancipation?
SGLT2 inhibition eliminates senescent cells and alleviates pathological aging
SGK1 inhibition-induced autophagy impairs prostate cancer metastasis by reversing EMT
SGLT2 inhibition and adipose tissue metabolism: current outlook and perspectives
SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice
Reversing the proverb
Reversing Event Structures
SGLT2-inhibition in patients with Alport syndrome
SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob−/− mice
Reversing Fields
Reversing Emissions
Reversing Emancipation?
SGLT2 inhibition eliminates senescent cells and alleviates pathological aging
SGK1 inhibition-induced autophagy impairs prostate cancer metastasis by reversing EMT
SGLT2 inhibition and adipose tissue metabolism: current outlook and perspectives
SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice
Reversing the proverb
Reversing Event Structures
SGLT2-inhibition in patients with Alport syndrome
SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob−/− mice
Reversing Fields
Reversing Emissions
Reversing Emancipation?
SGLT2 inhibition eliminates senescent cells and alleviates pathological aging
SGK1 inhibition-induced autophagy impairs prostate cancer metastasis by reversing EMT
SGLT2 inhibition and adipose tissue metabolism: current outlook and perspectives
SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice
Reversing the proverb